Page 82 - SPONDYLOARTHRITIS IN COLOMBIA -

REFERENCES
1 2 3
4 5
6
7 8 9 10 11 12
13 14
15
16 17
18 19
Ogdie A, Schwartzman S, Husni ME. Recognizing and managing comorbidities in psoriatic arthritis. Curr Opin Rheumatol 2015;27:118-26
Sun LM, Muo CH, Liang JA, Chang SN, Sung FC, Kao CH. Increased risk of cancer for patients with ankylosing spondylitis: a nationwide population-based retrospective cohort study. Scand J Rheumatol 2014;43:301-6
Germano V, Cattaruzza MS, Osborn J, Tarantino A, Di Rosa R, Salemi S, et al. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists. J Transl Med 2014;22:12:77
Prati C, Claudepierre P, Pham T, Wendling D. Mortality in spondyloarthritis. Joint Bone Spine 2011;78:466-70 Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and
cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 2011;63:550-6
Gherghe AM, Dougados M, Combe B, Landewé R, Mihai C, Berenbaum F, et al. Cardiovascular and selected comor-
bidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR co-
horts. RMD Open 2015;14;1(1):e000128
Mathieu S, Motreff P, Soubrier M. Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine
2010;77:542–5
McCarey D, Sturrock RD. Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis. Clin
Exp Rheumatol 2009;27:S124–6
Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, et al. Ankylosing spondylitis and risk of
ischaemic heart disease: a population-based cohort study Ann Rheum Dis 2016;75:203-9
Carmona L, Hernández-García C, Vadillo C, Pato E, Balsa A, González-Alvaro I, et al. Increased Risk of Tuberculosis
in Patients with Rheumatoid Arthritis. J Rheumatol 2003;30:1436–9
Franks AL, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 2012;32:1119–36
Moltó A, Enchuto A, van der Heijde D, Landewé R, van den Bosch F, Bautista-Molano W, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS- COMOSPA study. Ann Rheum Dis 2016;75:1016-23
Schargrodsky H, Hernández-Hernández R, Champagne BM, Silva H, Vinueza R, Silva Aycaquer LC, et al. CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008;121:58-65
Hernández-Hernández R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hyper- tens 2010;28:24–34
Raviglione M, Global Tuberculosis report 2015 World Health Organization (WHO). Available from:
http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1, accessed on 30/01/2016
Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008.
Int J Cancer 2013;132:1133-45
Ferlay J, Soerjomataram I, Ervik M. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC
Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 27/10/2015.
Wilson EB. Probable Inference, the Law of Succession, and Statistical Inference. J Am Stat Assoc 1927;22:209-12. Wallis S. Binomial Confidence Intervals and Contingency Tests: Mathematical Fundamentals and the Evaluation of
Alternative Methods. Journal of Quantitative Linguistics 2013;20:178-208 20
22
23 24
25 26
Heslinga SC, Van den Oever IA, Van Sijl AM, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, et al. Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation BMC Musculoskelet Disord 2015;16:80
Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study. Ann Intern Med 2015;163:409-16
Sundström B, Johansson G, Johansson I, Wallberg-Jonsson S. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis. Clin Rheumatol 2014:33:111-7
Connolly M, Nunn P. Women and tuberculosis. World Health Stat Q 1996;49:115-9
Munayco CV, Mújica OJ, León FX, del Granado M, Espinal MA. Social determinants and inequalities in tuberculosis
incidence in Latin America and the Caribbean. Rev Panam Salud Publica 2015;38:177–85
Mathieu S, Gossec L, Dougados M, Soubrier M. Cardiovascular profile in ankylosing spondylitis: a systematic review
and meta-analysis. Arthritis Care Res 2011;63:557–63
21 Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72
80